期刊文献+

C反应蛋白基因对HepG2.215细胞株乙型肝炎病毒复制的影响

Effect of CRP Gene on HBV Replication in HepG2.215 Cell Lines
下载PDF
导出
摘要 目的探讨C反应蛋白(C-reactive protein,CRP)基因对肝癌HepG2.215细胞株乙型肝炎病毒(HBV)复制的影响。方法用CRP基因过表达载体、CRP基因沉默载体、CRP基因突变载体及CRP基因空载体的慢病毒转染并筛选HepG2.215细胞稳定株进行研究。分为实验组、阴性对照组和空白对照组。采用RT-qPCR检测各组CRPmRNA表达水平,Western blot检测CRP蛋白表达水平,定量PCR检测HBVcccDNA、HBVDNA表达水平,免疫荧光检测乙型肝炎病毒核心抗原(HBcAg)表达情况,透射电镜检查观察HepG2.215细胞病毒复制情况,采用ELISA检测培养上清中HBsAg、HBeAg的表达水平,采用RT-qPCR检测HBVmRNA、HBVpgRNA的表达。结果CRP在HepG2.215细胞中的表达高于HepG2细胞(P<0.05)。CRP基因过表达组与阴性对照组相比较,HepG2.215细胞CRP蛋白和CRPmRNA、HBVcccDNA、HBVpgRNA及HBcAg表达升高,沉默CRP基因上述各项指标表达水平下降(P均<0.05);CRP基因过表达组与空白对照组相比较,HepG2.215细胞HBVmRNA、HBVDNA、HBsAg、HBeAg表达水平升高;CRP基因沉默组与空白对照组相比较,上述各项指标表达均降低(P均<0.05);CRP基因突变表达组与空白对照组相比较,HepG2.215细胞HBsAg表达水平升高(P<0.05)。结论CRP可促进肝癌HepG2.215细胞HBV的复制,并促进HBV相关抗原HBsAg、HBeAg、HBcAg的表达。CRP突变对HBsAg表达有一定促进作用。 Objective The aim of this study was to investigate the effect of CRP gene on HBV replication in hepatocellular carcinoma HepG2.215 cell lines.Methods HepG2.215 cells were transfected with lentivirus containing CRP gene overexpression vector,CRP gene silencing vector,CRP gene mutation vector and CRP gene empty vector respectively,and stable cell lines of HepG2.215 were screened for subsequent experiments,which were divided into experimental groups,negative control groups and blank control groups.the expression of CRPmRNA were detected by RT-qPCR and the CRP protein were detected by Western blot,the expression of HBVcccDNA and HBVDNA were detected by quantitative PCR,the expression of HBcAg was detected by immunofluorescence and transmission electron microscopy(TEM)was used to observe HBV virus replication.The expression of HBsAg and HBeAg in culture supernatants were detected by ELISA.RT-qPCR were used to detect HBVmRNA and HBVpgRNA.Results The expression of CRP in HepG2.215 cells was significantly increased compared with that in HepG2 cells(P<0.05).The overexpression group compared with the negative control group,the expression of CRP protein and CRPmRNA,HBVcccDNA,HBVpgRNA and HBcAg in HepG2.215 cells were significantly increased,and the expression of the above indicators of silencing CRP gene were decreased(P all<0.05).The expression levels of HBVmRNA,HBVDNA,HBsAg and HBeAg in HepG2.215 cells were significantly increased in the CRP gene overexpression group compared with the blank control group,while the expression levels of the above indicators were decreased in the CRP gene silenced group compared with the blank control group(P all<0.05).Compared with the blank control group,the expression level of HBsAg in HepG2.215 cells was increased in CRP gene mutated group(P<0.05).Conclusion CRP can promote HBV replication and the expression of HBsAg,HBeAg and HBcAg in HepG2.215 hepatoma cells.CRP mutation can promote the expression of HBsAg.
作者 李娟 马丽娜 刘帅伟 雒夏 丁向春 LI Juan;MA Li'na;LIU Shuaiwei;LUO Xia;DING Xiangchun(Clinical College of Ningxia Medical University,Yinchuan 750004,China;Department of Infectious Diseases,General Hospital of Ningxia Medical University,Yinchuan 750004,China)
出处 《宁夏医科大学学报》 2022年第5期451-458,共8页 Journal of Ningxia Medical University
基金 国家自然科学基金项目(81760363)。
关键词 C反应蛋白 肝细胞癌 HepG2.215细胞 HBV复制 C-reactive protein hepatocellular carcinoma HepG2.215 cells HBV replication
  • 相关文献

参考文献8

二级参考文献73

  • 1Qing He,Qi-yuan Tang,Xiao-hua Le,De-liang Lv,Xiang-mei Zhang,Fei-jian Ao,Yi-min Tang,Shan Huang,John Nunnari,Gui-lin Yang.The Relationship between Intrahepatic Distribution of Hepatitis B Virus Core Antigen and Serum ALT, HBV DNA Levels and HBeAg Status[J].国际感染病学(电子版),2012,1(2):84-90. 被引量:4
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 3向光明,钟森,赵川,邓存良,史晓玲,周陶友,唐红.肝细胞癌患者血清乙型肝炎病毒X区及前S/S区基因变异特点[J].中华肝脏病杂志,2007,15(2):146-148. 被引量:5
  • 4World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection[EB/OL].(2015-3-15)[2015-09-22].http://www.who.int/hiv/pub/hepatitis/hepatitis-b-guidelines/en/.
  • 5World Health Organization. Hepatitis B[EB/OL].(2015-7-28) [2015-09-22].http://www.who.int/mediacentre/factsheets/fs204/en/.
  • 6Tseng TC, Kao JH, Chen DS, et al. Peginterferon alpha in the treatment of chronic hepatitis B[J].Expert Opin Biol Ther, 2014, 14(7): 995-1006.
  • 7Gish RG, Clark MD, Kane SD, et al. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B[J].Clin Gastroenterol H, 2012, 10(8): 941-6; quiz e68.
  • 8Govan L, Wu O, Xin Y, et al. Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis[J].Eur J Gastroen Hepat, 2015, 27(8): 882-894.
  • 9Koklu S, Tuna Y, Gulsen MT, et al. Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis[J].Clin Gastroenterol H, 2013, 11(1): 88-94.
  • 10Lai CL, Ahn SH, Lee KS, et al. Phase Ⅱb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B[J].Gut, 2014, 63(6): 996-1004.

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部